Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 41, Issue 5, Pages 1171-1182
Publisher
Oxford University Press (OUP)
Online
2015-04-03
DOI
10.1093/schbul/sbv032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different Dopaminergic Abnormalities Underlie Cannabis Dependence and Cannabis-Induced Psychosis
- (2014) Robin M. Murray et al. BIOLOGICAL PSYCHIATRY
- Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior
- (2014) Marco Colizzi et al. NEUROPSYCHOPHARMACOLOGY
- Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2
- (2014) Paolo Taurisano et al. Frontiers in Behavioral Neuroscience
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
- (2013) Alice Egerton et al. BIOLOGICAL PSYCHIATRY
- Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
- (2013) Michael A.P. Bloomfield et al. BIOLOGICAL PSYCHIATRY
- Schizophrenia: an integrated sociodevelopmental-cognitive model
- (2013) Oliver D Howes et al. LANCET
- COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
- (2013) Antonio Verdejo-García et al. NEUROPSYCHOPHARMACOLOGY
- Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
- (2013) M. Di Forti et al. SCHIZOPHRENIA BULLETIN
- Cannabis users have higher premorbid IQ than other patients with first onset psychosis
- (2013) Laura Ferraro et al. SCHIZOPHRENIA RESEARCH
- Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene With Prefrontal Function and Olanzapine Treatment
- (2013) Giuseppe Blasi et al. JAMA Psychiatry
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- Puzzling over schizophrenia: Schizophrenia, social environment and the brain
- (2012) Heike Tost et al. NATURE MEDICINE
- A Critical Review of the First 10 Years of Candidate Gene-by-Environment Interaction Research in Psychiatry
- (2011) Laramie E. Duncan et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Molecular Genetics of Executive Function: Role of Monoamine System Genes
- (2011) Jessica J.M. Barnes et al. BIOLOGICAL PSYCHIATRY
- Cannabis, COMT and psychotic experiences
- (2011) Stanley Zammit et al. BRITISH JOURNAL OF PSYCHIATRY
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain
- (2011) Javier Costas et al. SCHIZOPHRENIA RESEARCH
- Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects
- (2010) Ruud van Winkel ARCHIVES OF GENERAL PSYCHIATRY
- The environment and schizophrenia
- (2010) Jim van Os et al. NATURE
- Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance
- (2010) Alessandro Bertolino et al. PLoS One
- DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia
- (2010) G. Blasi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabis users differ from non-users on measures of personality and schizotypy
- (2010) Daniel J. Fridberg et al. PSYCHIATRY RESEARCH
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?
- (2009) Lynn E DeLisi CURRENT OPINION IN PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Functional Variation of the Dopamine D2 Receptor Gene Is Associated with Emotional Control as well as Brain Activity and Connectivity during Emotion Processing in Humans
- (2009) G. Blasi et al. JOURNAL OF NEUROSCIENCE
- The role of cannabis in cognitive functioning of patients with schizophrenia
- (2009) Thomas Schnell et al. PSYCHOPHARMACOLOGY
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia
- (2008) Alessandro Bertolino et al. BRAIN
- Computational models of schizophrenia and dopamine modulation in the prefrontal cortex
- (2008) Edmund T. Rolls et al. NATURE REVIEWS NEUROSCIENCE
- Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
- (2008) J. van Os et al. SCHIZOPHRENIA BULLETIN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started